Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-27
2007-02-27
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S272000, C544S319000, C544S320000, C544S321000
Reexamination Certificate
active
10808146
ABSTRACT:
Disclosed are compounds Formula Iand pharmaceutically acceptable salts thereof, wherein R1, R2, R4, and R5are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.
REFERENCES:
patent: WO 01/29010 (2001-04-01), None
Trandism Cell Biology; 7; 353-361; 1997.
Mol. Cell Biology; 19; 21-30; 1999.
Embo J.; 20; 466-479; 2001.
Paul et al; Cell Signal; 9; 403-410; 1997.
Lee et al; Nature; 372; 376; 1994.
J. Biol. Chem; 274; 6272; 1999.
JPET; 293; 281; 2000.
Boehm et al; Exp Opin Ther Patents; 10; 25; 2000.
Rev. Infect. Disease; 6; 51; 1984.
Lymphokien Cytokine Res.; 11; 253-256; 1992.
Clin. Exp. Immunol.; 989; 244-250; 1992.
Perretti, M et al; Br. J. Pharmacol; 110; 868-874; 1993.
J. M. Stuart; Collagen Autoimmune Arthritis; Annual Rev. Immunol; 2; 199; 1984.
Lappin Julie M.
Pharmacia Corporation
LandOfFree
Substituted pyrimidinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrimidinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrimidinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3853121